• ABT-888 (Veliparib): Applied Workflows for DNA Repair Inhibi

  2026-07-31

  ABT-888 (Veliparib) empowers precise DNA repair inhibition, enabling researchers to sensitize cancer models to chemotherapy and radiation with reproducible, high-impact workflows. This guide details experimental setups, troubleshooting strategies, and actionable insights for maximizing the compound’s utility in advanced oncology research.

• Strategic JAK/STAT Pathway Modulation: Ruxolitinib Phosphate

  2026-07-31

  This article provides actionable, mechanistic insights into the use of Ruxolitinib phosphate (INCB018424) for translational researchers. Synthesizing the latest evidence on JAK/STAT pathway targeting in anaplastic thyroid carcinoma, it bridges bench-to-bedside challenges and outlines protocol guidance, workflow optimization, and strategic perspectives for advancing autoimmune and oncologic disease models.

• ARCA Cy5 EGFP mRNA (5-moUTP): Quantifying mRNA Fate In Situ

  2026-07-30

  Explore how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, unlocks real-time quantification of intracellular mRNA fate and translation efficiency. This article delivers a uniquely practical framework for dissecting delivery, immune evasion, and protein output in mammalian cell assays.

• Diethylmaleate in Redox Regulation and Insecticide Resistanc

  2026-07-30

  Diethylmaleate is a glutathione-depleting compound pivotal for oxidative stress research and toxicology. Recent studies confirm its role as a potent GST inhibitor, increasing insecticide sensitivity in resistant Megalurothrips usitatus. This article reviews the mechanistic, experimental, and workflow aspects of Diethylmaleate for advanced redox regulation studies.

• Palmitic acid (Hexadecanoic Acid): Technical Guide for Resea

  2026-07-29

  Palmitic acid (SKU N2456) provides a high-purity, well-characterized saturated long-chain fatty acid for controlled studies of lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It is unsuitable for protocols requiring aqueous solubility or long-term solution storage, making precise handling and prompt use essential for reliable results.

• Demethyleneberberine Triggers Cell Cycle Arrest in NSCLC via

  2026-07-29

  This article examines the pivotal study demonstrating that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, suppresses non-small cell lung cancer (NSCLC) by inducing cell cycle arrest and senescence via downregulation of the c-Myc/HIF-1α pathway. These findings highlight a promising mechanistic avenue for anti-cancer research and the development of targeted therapeutics.

• Phosphatase Inhibitor Cocktail: Precision in Phosphorylation

  2026-07-28

  The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) from APExBIO empowers researchers to preserve protein phosphorylation with exceptional fidelity, even in complex workflows like stem cell signaling and osteogenic differentiation studies. Its dual-tube design enables targeted inhibition for both serine/threonine and tyrosine phosphatases, streamlining sample preparation for immunoblotting, kinase assays, and advanced phosphoproteomics.

• Cytochalasin B (NSC 107658): Precision Modulation of Actin D

  2026-07-28

  Explore the advanced role of Cytochalasin B as a cytoskeletal research tool and drug discovery cytoskeleton modulator. This article delivers a deep-dive into precision actin modulation, practical assay design, and novel research insights, distinguishing itself from previous content.

• Temozolomide in Experimental Oncology: Mechanistic Precision

  2026-07-27

  Explore how Temozolomide, a small-molecule alkylating agent, enables high-resolution DNA repair mechanism research and advances protocol design in preclinical cancer models. This article uniquely dissects protocol variables and leverages recent evidence to guide optimization.

• Diuron-Induced Acute Kidney Injury: JAK2/STAT1 Pathway Insig

  2026-07-27

  This study integrates network toxicology, transcriptomics, and in vitro validation to uncover how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury via JAK2/STAT1 signaling. The findings provide mechanistic clarity for environmental toxicology research and inform risk assessment strategies related to persistent herbicide exposure.

• Diminazene Aceturate in Parasitic and Cardiovascular Researc

  2026-07-26

  Diminazene Aceturate stands out as a dual-purpose tool, enabling both trypanosome parasite elimination and advanced mitochondrial biogenesis studies through ACE2 activation. This article delivers workflow optimizations and troubleshooting insights for laboratories seeking robust, cross-domain applications.

• Sulfo-Cy3 Azide: Strategic Fluorescent Labeling in Neurogene

  2026-07-25

  This article explores the mechanistic advantages and translational impact of Sulfo-Cy3 azide as a bioconjugation reagent for Click Chemistry fluorescent labeling, with a focus on neurodevelopmental research. Drawing on recent mapping of Nurr1-positive neurons in the rat claustrum, we detail workflow parameters and competitive advantages relevant to modern translational researchers. The discussion bridges evidence from foundational studies, highlights current best practices, and projects the evolving landscape of high-fidelity, photostable fluorescent labeling in complex biological systems.

• TP53 and DNA Damage Pathways Shape Calicheamicin ADC Sensiti

  2026-07-24

  This study employs genome-wide CRISPR screening to elucidate DNA damage response genes, especially TP53, ATM, and MDM2, as crucial determinants of acute leukemia cell sensitivity to calicheamicin-based antibody–drug conjugates. The findings inform rational development of targeted combination therapies to overcome resistance and improve treatment outcomes in acute leukemia.

• Viral vIRD-Mediated RIPK3 Degradation Shapes Inflammatory Re

  2026-07-24

  Liu et al. uncover a class of orthopoxvirus proteins (vIRD) that engage the host ubiquitin-proteasome system to degrade RIPK3, thus suppressing necroptosis and modulating virus-induced inflammation. This mechanistic insight redefines our understanding of host-pathogen interactions and provides a new perspective for ubiquitin-proteasome pathway research.

• Niclosamide in Cancer Research: Protocols, Workflows, and Tr

  2026-07-23

  Niclosamide (5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) is a powerful STAT3 signaling pathway inhibitor for cancer research, offering robust cell cycle arrest and apoptosis induction. This article details evidence-driven workflows, practical protocol enhancements, and advanced troubleshooting strategies, empowering researchers to achieve high reproducibility and clear mechanistic insights.

16335 records 1/1089 page Next 12345 下5页 Last page